146 related articles for article (PubMed ID: 7815880)
21. Acanthamoeba keratitis related to orthokeratology.
Lee JE; Hahn TW; Oum BS; Choi HY; Yu HS; Lee JS
Int Ophthalmol; 2007 Feb; 27(1):45-9. PubMed ID: 17377749
[TBL] [Abstract][Full Text] [Related]
22. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
[TBL] [Abstract][Full Text] [Related]
23. Recent cluster of childhood microbial keratitis due to orthokeratology.
Tran T; Samarawickrama C; Petsoglou C; Watson S
Clin Exp Ophthalmol; 2014 Nov; 42(8):793-4. PubMed ID: 24533751
[No Abstract] [Full Text] [Related]
24. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
Larkin DF; Kilvington S; Dart JK
Ophthalmology; 1992 Feb; 99(2):185-91. PubMed ID: 1553206
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.
Carrijo-Carvalho LC; Sant'ana VP; Foronda AS; de Freitas D; de Souza Carvalho FR
Surv Ophthalmol; 2017; 62(2):203-218. PubMed ID: 27836717
[TBL] [Abstract][Full Text] [Related]
26. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine.
Narasimhan S; Madhavan HN; K LT
Cornea; 2002 Mar; 21(2):203-5. PubMed ID: 11862096
[TBL] [Abstract][Full Text] [Related]
27. Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
Kowalski RP; Abdel Aziz S; Romanowski EG; Shanks RM; Nau AC; Raju LV
JAMA Ophthalmol; 2013 Nov; 131(11):1459-62. PubMed ID: 24077460
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Acanthamoeba keratitis.
Lindquist TD
Cornea; 1998 Jan; 17(1):11-6. PubMed ID: 9436874
[TBL] [Abstract][Full Text] [Related]
29. [Acanthamoeba keratitis treated with propamidine and polyhexamethyl biguanide (PHMB)].
Donoso R; Mura JJ; López M
Rev Med Chil; 2002 Apr; 130(4):396-401. PubMed ID: 12090104
[TBL] [Abstract][Full Text] [Related]
30. A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba keratitis.
Bagga B; Sharma S; Gour RPS; Mohamed A; Joseph J; M Rathi V; Garg P
Eye (Lond); 2021 May; 35(5):1326-1333. PubMed ID: 32719525
[TBL] [Abstract][Full Text] [Related]
31. Phagocytosis affects biguanide sensitivity of Acanthamoeba spp.
Noble JA; Ahearn DG; Avery SV; Crow SA
Antimicrob Agents Chemother; 2002 Jul; 46(7):2069-76. PubMed ID: 12069957
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
Martín-Pérez T; Lozano-Cruz T; Criado-Fornelio A; Ortega P; Gómez R; de la Mata FJ; Pérez-Serrano J
Parasitol Res; 2019 Jun; 118(6):1953-1961. PubMed ID: 31069536
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
Valluri S; Fleming TP; Laycock KA; Tarle IS; Goldberg MA; Garcia-Ferrer FJ; Essary LR; Pepose JS
Cornea; 1997 Sep; 16(5):556-9. PubMed ID: 9294689
[TBL] [Abstract][Full Text] [Related]
34. Polyhexamethylene biguanide and chloroquine induce programmed cell death in Acanthamoeba castellanii.
Moon EK; Choi HS; Kong HH; Quan FS
Exp Parasitol; 2018 Aug; 191():31-35. PubMed ID: 29885293
[TBL] [Abstract][Full Text] [Related]
35. Acanthamoeba keratitis in Porto Alegre (southern Brazil): 28 cases and risk factors.
Dos Santos DL; Kwitko S; Marinho DR; de Araújo BS; Locatelli CI; Rott MB
Parasitol Res; 2018 Mar; 117(3):747-750. PubMed ID: 29332157
[TBL] [Abstract][Full Text] [Related]
36. [Good outcome in Acanthamoeba keratitis].
Reichart-Peter S; Manousaridis K; Dirschmid H; Mennel S
Ophthalmologe; 2017 Jul; 114(7):653-655. PubMed ID: 27558689
[TBL] [Abstract][Full Text] [Related]
37. Contact lens-related polymicrobial keratitis: Acanthamoeba spp. genotype T4 and Candida albicans.
Buchele MLC; Wopereis DB; Casara F; de Macedo JP; Rott MB; Monteiro FBF; Bazzo ML; Dos Reis Spada F; Dos Santos JI; Caumo KS
Parasitol Res; 2018 Nov; 117(11):3431-3436. PubMed ID: 30094541
[TBL] [Abstract][Full Text] [Related]
38.
Papa V; Rama P; Radford C; Minassian DC; Dart JKG
Br J Ophthalmol; 2020 Apr; 104(4):575-581. PubMed ID: 31401556
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Acanthamoeba keratitis.
Seal D
Expert Rev Anti Infect Ther; 2003 Aug; 1(2):205-8. PubMed ID: 15482114
[TBL] [Abstract][Full Text] [Related]
40. Cosmetic contact lens-related Acanthamoeba keratitis.
McKelvie J; Patel D; McGhee C
Clin Exp Ophthalmol; 2009 May; 37(4):419-20. PubMed ID: 19594573
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
